Company reports EPS of $4.92, Economic EPS of $6.53 in the fourth quarter of 2024EPS of $15.13, Economic EPS of $21.36 for the full year 2024 New partnership with NorthBridge Partners, a private ...
Magnera's solid fiscal Q1 results were better than prior year despite currency headwinds and reflect our ability to remain focused on day-to-day business execution, while managing the post-transaction ...
Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...
Adjusted net earnings were up 4.1% in Q4 to $719 million, delivering a 3.9% increase in adjusted EPS to $0.79. For full-year 2024, adjusted net earnings were down 5.2% to $2,773 million, resulting in ...